Major response to temozolomide as first-line treatment for newly-diagnosed DDR2-mutated glioblastoma: A case report

Autor: El Husseini, K., Marguet, F., Lamy, A., Magne, N., Fontanilles, M. *
Zdroj: In Revue Neurologique May 2020 176(5):402-404
Databáze: ScienceDirect